Aberrant messenger RNA splicing of the cytokeratin 8 in lung cancer.

[1]  M. Hesse,et al.  Genes for intermediate filament proteins and the draft sequence of the human genome: novel keratin genes and a surprisingly high number of pseudogenes related to keratin genes 8 and 18. , 2001, Journal of cell science.

[2]  Yasufumi Yamaji,et al.  The role of caspase 3 in producing cytokeratin 19 fragment (CYFRA21‐1) in human lung cancer cell lines , 2001, International journal of cancer.

[3]  M. Omary,et al.  The cytoskeleton of digestive epithelia in health and disease. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[4]  J. Fujita,et al.  Expression of nerve growth factor-induced clone B subfamily and pro-opiomelanocortin gene in lung cancer cell lines. , 1999, American journal of respiratory cell and molecular biology.

[5]  A D Irvine,et al.  Human keratin diseases: the increasing spectrum of disease and subtlety of the phenotype–genotype correlation , 1999, The British journal of dermatology.

[6]  L. Bruckner-Tuderman,et al.  Novel K5 and K14 mutations in German patients with the Weber-Cockayne variant of epidermolysis bullosa simplex. , 1998, The Journal of investigative dermatology.

[7]  Stanley N Cohen,et al.  The TSG101 Tumor Susceptibility Gene Is Located in Chromosome 11 Band p15 and Is Mutated in Human Breast Cancer , 1998, Cell.

[8]  E. Fuchs,et al.  A structural scaffolding of intermediate filaments in health and disease. , 1998, Science.

[9]  Stanley N Cohen,et al.  Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours , 1997, Oncogene.

[10]  G. Salvesen,et al.  Caspase Cleavage of Keratin 18 and Reorganization of Intermediate Filaments during Epithelial Cell Apoptosis , 1997, The Journal of cell biology.

[11]  A. Feinberg,et al.  Aberrant splicing but not mutations of TSG101 in human breast cancer. , 1997, Cancer research.

[12]  M. Omary,et al.  Stress, Apoptosis, and Mitosis Induce Phosphorylation of Human Keratin 8 at Ser-73 in Tissues and Cultured Cells* , 1997, The Journal of Biological Chemistry.

[13]  G. Giaccone,et al.  FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. , 1997, Cancer research.

[14]  E. White,et al.  Lamin proteolysis facilitates nuclear events during apoptosis , 1996, The Journal of cell biology.

[15]  C. Caulin,et al.  Oncogenic regulation and function of keratins 8 and 18 , 1996, Cancer and Metastasis Reviews.

[16]  C. Croce,et al.  The FHIT gene at 3p14.2 is abnormal in breast carcinomas. , 1996, Cancer research.

[17]  Stanley N Cohen,et al.  tsg101: A Novel Tumor Susceptibility Gene Isolated by Controlled Homozygous Functional Knockout of Allelic Loci in Mammalian Cells , 1996, Cell.

[18]  J. Bonifas,et al.  Keratin 14 gene mutations in patients with epidermolysis bullosa simplex. , 1995, The Journal of investigative dermatology.

[19]  Seamus J. Martin,et al.  Protease activation during apoptosis: Death by a thousand cuts? , 1995, Cell.

[20]  I. Leigh,et al.  Missing links: Weber–Cockayne keratin mutations implicate the L12 linker domain in effective cytoskeleton function , 1993, Nature Genetics.

[21]  S. T. Traweek,et al.  Keratin gene expression in non-epithelial tissues. Detection with polymerase chain reaction. , 1993, The American journal of pathology.

[22]  F. Ramaekers,et al.  Intermediate filaments as differentiation markers of normal pancreas and pancreas cancer. , 1992, The American journal of pathology.

[23]  P. Yaswen,et al.  Keratins as markers that distinguish normal and tumor-derived mammary epithelial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[24]  W. Franke,et al.  Organization and sequence of the human gene encoding cytokeratin 8. , 1990, Gene.

[25]  D J Ruiter,et al.  Distribution of cytokeratin polypeptides in human transitional cell carcinomas, with special emphasis on changing expression patterns during tumor progression. , 1990, The American journal of pathology.

[26]  S. Wagenaar,et al.  Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies. , 1988, Cancer research.

[27]  W. Franke,et al.  Pair formation and promiscuity of cytokeratins: formation in vitro of heterotypic complexes and intermediate-sized filaments by homologous and heterologous recombinations of purified polypeptides , 1985, The Journal of cell biology.

[28]  Benjamin Geiger,et al.  The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells , 1982, Cell.

[29]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[30]  W. Idler,et al.  Self-assembly of bovine epidermal keratin filaments in vitro. , 1976, Journal of molecular biology.

[31]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[32]  福永 洋子.  Expression of cytokeratin 8 in lung cancer cell lines and measurement of serum cytokeratin 8 in lung cancer patients , 2003 .

[33]  Christopher J. Lee,et al.  A genomic view of alternative splicing , 2002, Nature Genetics.

[34]  A. J. Lopez,et al.  Alternative splicing of pre-mRNA: developmental consequences and mechanisms of regulation. , 1998, Annual review of genetics.

[35]  M. Lavin,et al.  The ICE family of cysteine proteases as effectors of cell death. , 1996, Cell death and differentiation.

[36]  M. Walshaw,et al.  Simple cytokeratins in the serum of patients with lung cancer: relationship to cell death. , 1994, European journal of cancer.

[37]  K Weber,et al.  Intermediate filaments: structure, dynamics, function, and disease. , 1994, Annual review of biochemistry.

[38]  F. Mansergh,et al.  A mutation (met→arg) in the type I keratin (K14) gene responsible for autosomal dominant epidermolysis bullosa simplex , 1993, Human mutation.

[39]  P M Steinert,et al.  Molecular and cellular biology of intermediate filaments. , 1988, Annual review of biochemistry.

[40]  G. Blobel,et al.  Cytokeratins in normal lung and lung carcinomas , 1984, Virchows Archiv. B, Cell pathology including molecular pathology.

[41]  A. Wyllie,et al.  Cell death: the significance of apoptosis. , 1980, International review of cytology.